6 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are
Read More
Part D/Prescription Drugs
Medicare Advantage open enrollment is coming
Did you know Medicare has several different enrollment periods with separate rules for each? There is an Initial enrollment period,
Read MoreThe 3 conditions driving healthcare costs up for employers: Report
(By Mariah Taylor for Becker’s Hospital Review) Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare costs
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More5 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) About two-thirds of providers recently told Premier their teams are spending more than
Read MoreWeight loss drugs could cost Medicare $6B a year: Study
(By Rylee Wilson for Becker’s Hospital Review) Medicare spending could increase between $3.1 billion and $6.1 billion annually if the
Read MoreWhile Medicare Drug Price Negotiations Don’t Apply to Private Insurance, 3.4 Million People with Employer Coverage Take at Least One of the Selected Drugs
(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in
Read MoreMedicare negotiated drug prices for the first time. Here’s what it got
(By Sydney Lupkin, Asma Khalid for NPR) The White House unveiled the fruits of months of negotiations between the government
Read MoreMajority of weight loss drug prescriptions going to commercially insured patients
(By Jakob Emerson for Becker’s Hospital Review) In 2023, more than 61% of Ozempic prescriptions went to patients with commercial
Read MoreFDA calls out Bristol Myers over cancer drug claims
(By Elizabeth Gregerson for Becker’s Hospital Review) The FDA has accused pharmaceutical company Bristol Myers Squibb of making false or
Read More